Cervical Cancer

Non-speculum sampling by clinicians and self-sampling “substantially increased” cervical cancer screening uptake in women aged 50 to 64 years who were overdue for screening, according to researchers.

An increasing percentage of lung cancer cases are being diagnosed at an earlier stage, according to a new report from American Cancer Society.

Cervical cancer is the fourth most common cancer among women, according to WHO. In 2018, it caused an estimated 311,000 deaths worldwide.

COVID-19 dominated headlines in 2021, but breast, cervical and ovarian cancers remain leading causes of mortality among women. Here are our top stories about new research designed to save lives for the year.

Women who became pregnant after fertility-sparing surgery for cervical cancer were more likely to have a preterm delivery compared with controls, according to results from a population-based cohort study.

Transgender men and nonbinary individuals derived benefit from a pilot program designed to offer cervical cancer screening specific to their biological needs and personal preferences, according to study results.

Unemployment appeared associated with a lower likelihood of having health insurance and of being up to date on cancer screening tests, according to results of a study published in Cancer.

A considerable proportion of women who never received an HPV vaccine also never underwent cervical cancer screening or were not up to date on screening in 2019, according to findings published in JAMA Network Open.

Although cervical cancer elimination appears to be within reach in the United States, a predictive model anticipated an approximately decade-long gap between low-poverty and high-poverty areas of the country in achieving this goal.

The FDA approved a combination of pembrolizumab and chemotherapy, with or without bevacizumab, for certain women with persistent, recurrent or metastatic cervical cancer.